Model Number |
Fresenius Drymeal A,B |
Haemodialysis Drymeal Package Insert Powder A Drug Name: Haemodialysis Drymeal A Mode: Available Model: Fresenius Composition The drug includes 1053.381 g NaCl, 32.616 g KCl, 38.588 g CaCl2, 17.789g MgCl2, 30.025 ml CH3COOH per pouch. Lndications To patients of Haemodialysis. Applicability The drug is intended to Haemodialysis of acute and chronic kindey failure, drug poisoning and electrolyte abnormalities. Administration 1. Freshly made before used, dissolve a pouch of A into dialysis water up to 5.0L, after being A, then being indicated in Haemodialysis on the condition of airproof 2. Drymeal being dissloved into solution in propotion with A: B: Water as 1: 1.225: 32.775. Dosage A pouch is enough for one patient to normally dialyze. Side Veffects and special precautions The drug may result in glycopenia to individual person because short of glucose special precautions: Intravenous Injection of 50 percent 40-60ml glucose, under the guidance of doctors according to patient s condition. Technical parameterAfter made up into solution based on insert, the consistency of electrolyte of solution (mmol/L) and pH number.
Insolubility Peck After the drug becoming solution according to administration, the contents of particles after deducting background are as follows: Pecks of not more than 10 gm is not more than 12 per ml. Pecks of not more than 25 gm is not more than 2 per ml. Limits of Microorganism The total bacterium of the solution according to proportion is less than 100CFU/ml, eumyophytais less than 10 CFU/ml, Escherichia coli hasn t been found out Pyrogen-free he toxinum in the bacterium is less than 0.5 EU/ml, after the drug is dissolved into dialysis fluid by toxinum check water according to insert Contraindications No absolutely contraindications. The relative contraindications are: Severe hypotension and shock; Edema of lungs and cardiac failure are caused by severe myocardism; Severe arrhythmia; Severe hemorrhagic tendency or cerebral hemorrhage; Late malignant tumors; Extreme exhaustion patients; Bedlams whom are uncooperative; The one whose identity or relatives are refusable. Precautions Note 1. A powder or B powder can be used separately and also can t be mixed directly. 2. If the packages are breakage or dialyzed powder discoloration before unsealing, the medicines strictly prohibit; Please use statimly after unseal.
3. This medicine should not be used in injection, peritoneal dialysis or hemofiltration, please according to the doctors advice to take it. Storage Lutation and store in a cool and dry place. Don t leave virulent, contaminative or odorant things with this medicine together. Dosage 1167.45g per accessory pocket Package Plastic bag Transport Demand According to order contract Batch No n sealing Production Time On sealing Validity month Product Standard YY0598-2006Hemodialysis and Correlative Cure Concentration
|